Supreme Court Denies Review in NFL Concussion Case, Clearing the Way for Landmark Settlement

On Monday, the United States Supreme Court denied challenges to the pending settlement reached among retired NFL players and the league, clearing the way for the benefits process to move forward. The Supreme Court’s decision to deny review removes the final obstacle to implementation of the landmark settlement to provide care for retired NFL players suffering from brain-related injuries […]

December 13, 2016

football

On Monday, the United States Supreme Court denied challenges to the pending settlement reached among retired NFL players and the league, clearing the way for the benefits process to move forward.

The Supreme Court’s decision to deny review removes the final obstacle to implementation of the landmark settlement to provide care for retired NFL players suffering from brain-related injuries as a result of hits sustained during their playing careers.

Christopher Seeger, co-lead counsel for the retired NFL player class plaintiffs, said, “This decision means that, finally, retired NFL players will receive much-needed care and support for the serious neurocognitive injuries they are facing. These courageous men and their families, who in the face of great adversity took on the NFL, have made history. Despite the difficult health situations retired players face today, and that many more will unfortunately face in the future, they can take comfort in the fact that this settlement’s significant and immediate benefits will finally become available to them and last for decades to come.”

“Today’s decision ushers in the benefits process, which we expect will open this spring. With a 99% participation rate in the settlement, and more than 11,000 retired players already pre-registering for benefits, it is clear these programs are highly anticipated by the NFL alumni community,” Mr. Seeger said. “Class members will soon be receiving more information by mail, and we encourage them to visit NFLconcussionsettlement.com for updates on the registration and claims process.”

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic $5.8 billion settlement with Johnson & Johnson to resolve all current and pending talcum powder claims in MDL No. 2738 […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More